Skip to main content

Jill Mesirov, Geoffrey Duyk, Joseph Catino, William Hancock, Brian Huber, Colin McKerlie


Jill Mesirov, CIO of the Whitehead/MIT Center for Genome Research, is one of six new members of the scientific advisory board of laboratory product and services company Charles River Laboratories of Wilmington, Mass. Other appointees include Geoffrey Duyk, CSO of Exelixis Pharmaceuticals; Joseph Catino, VP of Research of Bayer; William Hancock, chair in bioanalytical chemistry at the Barnett Institute at Northeastern University; Brian Huber, Vice President of the Biology Division, Drug Discovery, at GlaxoSmith-Kline; and Colin McKerlie, research scientist in the integrative biology program at the Hospital for Sick Children.

Filed under

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.